A Phase 1 Study of PROT-001.
Clinical trial NCT06981299 · COMPLETED
Trial details
- NCT number
- NCT06981299
- Sponsor
- Protego Biopharma Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2025-12-23
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.